Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate plus narrowband UVB phototherapy versus placebo plus phototherapy in adults with progressive vitiligo
2018-004536-29Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Vitiligo comparing Methotrexate + UVB TL01 phototherapy with Placebo + UVB TL01 phototherapy (2 arms). Started May 2019; status: active.
02
Drugs
methotrexate
03
Conditions
Vitiligo
Beyond the preview
Go deeper on 2018-004536-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004536-29.